Oct. 8, 2020 Vaccines currently being developed for COVID-19 should not be affected by recent mutations in the virus, according to a new ...
Oct. 7, 2020 Scientists have found an ingredient that makes a vaccine more effective through an approach more often seen in materials science -- testing molecules that self-assemble into larger ...
Oct. 5, 2020 Seasonal influenza vaccine development and mass production, as well as three international influenza vaccine cardiovascular outcomes trials currently underway, may inform future efforts targeted at ...
Oct. 2, 2020 The National Academies of Sciences, Engineering, and Medicine has released the final report of a consensus study recommending a four-phased equitable allocation framework that the US Department of ...
Oct. 1, 2020 Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. A new paper details the ...
Sep. 28, 2020 According to a new U.S. poll, COVID-19 may not influence parents' beliefs about the flu vaccine, with just one third believing it's more important for children to get vaccinated this year, ...
Sep. 23, 2020 A new survey of six U.S. states has found that during the past two months, more people are wearing masks, vaccine uncertainty is on the rise, and many people are overestimating their risk of becoming ...
Sep. 21, 2020 Using information from the Swedish public health agency, researchers determined that BCG vaccination during infancy does not protect against COVID-19. Their results suggest that other, related ...
Sep. 17, 2020 'Citizen scientists' developing homemade COVID-19 vaccines may believe they're inoculating themselves against the ongoing pandemic, but the practice of self-experimentation with ...
Sep. 17, 2020 A new study shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group with high rates of typhoid fever in ...
Sep. 10, 2020 Almost seven in 10 Americans would be interested in receiving a COVID-19 vaccine when one becomes available, according to a new study. But researchers say there are concerning gaps in interest, ...
Sep. 10, 2020 Combining their expertise in protein engineering and synthetic DNA technology, scientists successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and ...
Sep. 3, 2020 Nineteen global health experts from around the world have proposed a new, three-phase plan for vaccine distribution -- called the Fair Priority Model -- which aims to reduce premature deaths and ...
Sep. 3, 2020 New research demonstrates that a candidate COVID-19 vaccine elicited robust immune response in Syrian golden hamsters and prevented severe clinical disease -- including weight loss, pneumonia and ...
Sep. 2, 2020 A bioengineering technique to boost production of specific proteins could be the basis of an effective vaccine against the novel coronavirus that causes COVID-19, new research ...
Sep. 1, 2020 The BCG vaccine has a broad, stimulating effect on the immune system. BCG is frequently given to children, but a new study shows that elderly people also benefit from ...
Aug. 31, 2020 In a new article, researchers propose reforms that the U.S. Food and Drug Administration (FDA) could implement to improve the emergency use authorization process and drug approvals during public ...
Aug. 31, 2020 Repeated exposure to influenza viruses may undermine the effectiveness of the annual flu vaccine. A team of researchers has developed an approach to assess whether a vaccine activates the kind of ...
Aug. 31, 2020 A new mouse model is laying the groundwork for antivirals, vaccines and antibodies in the fight against COVID-19. In some cases, the model is the first to show these medical countermeasures work in a ...
Aug. 28, 2020 Influenza and pneumonia vaccinations are associated with fewer hospital deaths in patients with heart failure. That's the result of a study in nearly 3 million Americans. One out of five ...